Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;86(4):273-81.
doi: 10.4065/mcp.2010.0732. Epub 2011 Mar 9.

Medication adherence among community-dwelling patients with heart failure

Affiliations

Medication adherence among community-dwelling patients with heart failure

Shannon M Dunlay et al. Mayo Clin Proc. 2011 Apr.

Abstract

Objective: To determine medication use and adherence among community-dwelling patients with heart failure (HF).

Patients and methods: Residents of Olmsted County, Minnesota, with HF were recruited from October 10, 2007, through February 25, 2009. Pharmacy records were obtained for the 6 months after enrollment. Medication adherence was measured by the proportion of days covered (PDC). A PDC of less than 80% was classified as poor adherence. Factors associated with medication adherence were investigated.

Results: Among the 209 study patients with HF, 123 (59%) were male, and the mean ± SD age was 73.7 ± 13.5 years. The median (interquartile range) number of unique medications filled during the 6-month study period was 11 (8-17). Patients with a documented medication allergy were excluded from eligibility for medication use within that medication class. Most patients received conventional HF therapy: 70% (147/209) were treated with β-blockers and 75% (149/200) with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Most patients (62%; 127/205) also took statins. After exclusion of patients with missing dosage information, the proportion of those with poor adherence was 19% (27/140), 19% (28/144), and 13% (16/121) for β-blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, and statins, respectively. Self-reported data indicated that those with poor adherence experienced more cost-related medication issues. For example, those who adhered poorly to statin therapy more frequently reported stopping a prescription because of cost than those with good adherence (46% vs 6%; P < .001), skipping doses to save money (23% vs 3%; P = .03), and not filling a new prescription because of cost (46% vs 6%; P < .001).

Conclusion: Community-dwelling patients with HF take a large number of medications. Medication adherence was suboptimal in many patients, often because of cost.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Questionnaire administered to study patients.
FIGURE 2.
FIGURE 2.
Proportion of patients filling prescriptions, categorized by the number of unique medications.
FIGURE 3.
FIGURE 3.
Pharmacy-based medication adherence. The proportion of patients with poor medication adherence (PDC <80%) for each medication class are shown. Adherence was not calculated for loop diuretics because of frequent dosing changes. ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; PDC = proportion of days covered.

Comment in

References

    1. Writing Group Members Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published corrections appear in Circulation. 2010;122 (1):ell and 2009;119(3):e182] Circulation. 2009;119(3):e21-e181 - PubMed
    1. Writing Committee Members. Task Force Members ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2005;112(12):e154-e235 - PubMed
    1. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-725 - PubMed
    1. Wu JR, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14(3):203-210 - PMC - PubMed
    1. Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure. Clin Ther. 2007;29(8):1771-1783 - PubMed

Publication types

Substances